cGAMP as a potential biomarker for diagnosing triple-vessel coronary artery disease in diabetic patients

1 September 2025 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Cardiometabolic dysfunction in diabetes: inflammation, vascular injury, and molecular signatures Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by